-
The FTC began probing Amazon during the Trump administration. The company has been criticized for allegedly favoring its own products and disfavoring outside sellers on its platform, among other allegations.
-
Your daily TLDR of important AI stories you must know about.
-
The complaint from the Center for Artificial Intelligence and Digital Policy, which is led by longtime privacy advocate Marc Rotenberg, centers on GPT-4, the latest language model behind the research group OpenAI’s ChatGPT
-
The point of contention remains the lucrative Call of Duty franchise. Microsoft has said it was 'listening carefully to the European Commission's concerns' and is confident that these can be addressed
-
The ruling had been issued in a sealed form earlier this week.
-
This week the US FTC clamps down on MasterCard, India sets its deadline for the common charger directive, India recognizes eSports as an official sport, then we tell you about the best gaming laptop money can buy, Apple's run-in with Japan's taxation bureau and North Korea using state sponsored hackers to target South Korea policy makers
-
Mastercard has been ordered to provide competing payment networks access to debit card transcations
-
Both companies have submitted detailed filings with the FTC, denying the move is anti-competitive
-
Microsoft has been sued by 10 people who believe the merger will harm competition
-
A record fine of $275 million is for violating a child privacy law and $245 million for manipulating user purchasing practices
-
The FTC said it was committed to safeguarding users sensitive data
-
The lawsuit says that Twitter deceptively used people's phone numbers and email addresses to serve them ads
-
A damning report from Wall Street Journal alleged that CEO Bobby Kotick knew of the toxic work culture at Activision Blizzard
-
By fining Facebook, FTC will send a signal to all tech firms of more crackdowns. Regulators across the world may take a cue and start investigating social media firms soon.
-
The FTC said in a statement that it had reviewed whether the deal would substantially lessen competition or constituted an unfair method of competition and opted not to pursue its investigation further.
-
The US Federal Trade Commission filed a lawsuit in federal court in California claiming Qualcomm's practices amount to "unlawful maintenance of a monopoly in baseband processors," which are devices that enable cellular communications in phones and other products.
-
Verizon's general counsel Craig Silliman told reporters at a roundtable in Washington the data breach could trigger a clause in the deal that would allow the US wireless company not to complete it.
-
Officials from the US Federal Trade Commission have met with multiple Internet travel and hospitality companies in the last couple of weeks to talk about Google and gather information about the company's potentially anti-competitive practices on mobile.
-
Lupin, India's third-largest drugmaker by sales, last year said it would buy Gavis to revive flagging growth in the United States by giving it access to a number of generic drugs that treat niche diseases.
-
Rival technology companies allege that Google gives priority to its own services on Android while restricting those of competitors, the report said.
-
According to a statement issued by BioMarin, the US drugmaker said it will grant Dr Reddy's a non-exclusive licence to its patents on Kuvan (sapropterin dihydrochloride) allowing the Indian drug maker to market a generic version of Kuvan 100mg tablets in the US at a later stage, which is expected to be more than five years from now.
-
Shares of Ranbaxy Laboratories and Sun Pharmaceutical Industries hit record high on Monday, up 1-2 percent intraday on approval for USD 4 billion merger plan from Punjab & Haryana High Court.
-
The Sun-Ranbaxy merger now needs approval from just the Punjab and Haryana High Court. The court will be hearing on the merger on February 2. Sun Pharma had agreed to buy Ranbaxy from Japan's Daiichi Sankyo in April.
-
Approval subject to divestment of one antibiotic product to avoid anticompetitive impact in the US mkt.
-
According to a statement issued by the drug major, the acquisition of Habitrol brand (an over-the-counter nicotine replacement therapy transdermal patch) from Novartis Consumer Health Inc was done following issuance of the proposed consent order from the US Federal Trade Commission (FTC) on November 26.
